Residency · Residency · Preventive Medicine
LGBTQ+ Health Disparities and Inclusive Preventive Care
Introduction
LGBTQ+ encompasses lesbian, gay, bisexual, transgender, queer/questioning, and other sexual and gender minority populations. An estimated 7.2% of U.S. adults (approximately 20 million people) identify as LGBTQ+, with higher percentages among younger generations. LGBTQ+ populations experience significant health disparities driven by minority stress, discrimination, and barriers to culturally competent care. The National Academies of Sciences (2011, updated 2020) identified LGBTQ+ health as a critical area requiring dedicated research and policy attention.
Frameworks for Understanding LGBTQ+ Health
Minority Stress Theory
Minority stress (Ilan Meyer, 2003) posits that sexual and gender minorities experience chronic stress from stigma, prejudice, and discrimination. Distal stressors: External events including discrimination, violence, and microaggressions. Proximal stressors: Internalized homophobia/transphobia, expectations of rejection, concealment of identity. Resilience factors: Community connectedness, social support, positive identity, and coping strategies can buffer minority stress effects.
Intersectionality
LGBTQ+ individuals with intersecting marginalized identities (racial/ethnic minority, low income, disability, immigration status) face compounded health disparities. Black transgender women face the highest rates of violence, HIV infection, and barriers to care among all LGBTQ+ subgroups. Research and interventions must account for the diversity within LGBTQ+ populations rather than treating them as a monolithic group.
Health Disparities by Population
Lesbian and Bisexual Women
Higher rates of obesity and lower rates of physical activity compared to heterosexual women. Breast cancer risk may be elevated due to higher rates of nulliparity, obesity, and alcohol use. Lower rates of cervical cancer screening; misconception that Pap smears are unnecessary for women who have sex with women. Higher rates of intimate partner violence than commonly recognized; services are predominantly designed for heterosexual women. Bisexual women report the highest rates of mental health disorders, substance use, and sexual victimization.
Gay and Bisexual Men
HIV/AIDS: Men who have sex with men (MSM) account for approximately 67% of new HIV diagnoses in the U.S. despite representing 2-5% of the population. Higher rates of syphilis, gonorrhea, and other STIs; pharyngeal and rectal infections are frequently asymptomatic. HPV-related anal cancer: MSM have approximately 20 times the risk of the general male population; anal Pap screening is recommended by some guidelines. Substance use: Higher rates of methamphetamine, amyl nitrite (poppers), and alcohol use; chemsex presents unique harm reduction challenges. Body image concerns and eating disorders are more prevalent than in heterosexual men.
Transgender and Gender Diverse Individuals
Gender dysphoria and the experience of gender incongruence are associated with significant psychological distress when untreated. Gender-affirming hormone therapy (GAHT): Estrogen-based therapy for transfeminine individuals; testosterone for transmasculine individuals. Cardiovascular risk: Estrogen therapy may increase venous thromboembolism risk; testosterone may affect lipid profiles. Cancer screening must be based on anatomy, not gender identity: transgender men with cervices need Pap smears; transgender women with prostates need PSA screening if indicated. Transgender individuals face extreme barriers to care: approximately 33% report being refused medical care, and 23% avoid care due to fear of mistreatment. Suicide attempt rates among transgender individuals are approximately 40%, with rates decreasing significantly among those who receive gender-affirming care.
<image>Comprehensive diagram showing preventive care screening recommendations for transgender patients organized by organ system, with parallel columns for transmasculine and transfeminine individuals, indicating which screenings apply based on anatomy (cervix, breast tissue, prostate) regardless of gender identity, and how hormone therapy may modify screening intervals</image>
Mental Health
LGBTQ+ youth are 4 times more likely to attempt suicide than heterosexual peers; transgender youth are at even higher risk. Family rejection is a major risk factor: LGBTQ+ youth who experience high family rejection are 8.4 times more likely to attempt suicide. Conversion therapy (attempts to change sexual orientation or gender identity) is condemned by every major medical organization and associated with increased depression and suicidality. Protective factors include family acceptance, Gay-Straight Alliances (GSAs) in schools, and access to affirming mental health services.
Substance Use
LGBTQ+ adults have approximately 2-3 times higher rates of substance use disorders compared to heterosexual/cisgender adults. Tobacco use is 50% higher in LGB adults and even more elevated in transgender populations. Bars and clubs have historically served as primary social spaces, reinforcing the association between alcohol use and community. Targeted marketing by tobacco and alcohol industries toward LGBTQ+ communities has been documented.
<image>Infographic displaying the cascade of minority stress effects on LGBTQ+ health, starting with structural stigma (discriminatory laws, policies) and interpersonal discrimination, flowing through psychological mediators (internalized stigma, vigilance, concealment), physiological stress responses (HPA axis activation, inflammation), and resulting health outcomes (mental health disorders, substance use, cardiovascular disease, cancer), with protective factors (community, social support, affirming care) shown as buffering mechanisms</image>
Inclusive Preventive Care Practices
Clinical Environment
Inclusive intake forms with options for sexual orientation, gender identity, chosen name, and pronouns. Visible signals of inclusivity: Safe Space or rainbow signage, inclusive educational materials, gender-neutral restrooms. Staff training on LGBTQ+ cultural competency, including appropriate terminology and avoidance of assumptions. Electronic health record (EHR) systems should capture sexual orientation and gender identity (SOGI) data as recommended by Healthy People objectives.
Screening and Prevention
HIV screening: CDC recommends universal screening ages 13-64; PrEP (pre-exposure prophylaxis) for those at substantial risk. PrEP (emtricitabine/tenofovir or long-acting cabotegravir): Reduces HIV acquisition by over 99% when taken as prescribed; significant disparities exist in PrEP awareness and uptake by race. HPV vaccination: Recommended for all individuals through age 26 (and shared clinical decision-making through age 45) Hepatitis A and B vaccination: Recommended for MSM. STI screening: Comprehensive screening at all anatomic sites of exposure (pharyngeal, rectal, urogenital) at least annually for sexually active MSM. Behavioral health screening: PHQ-9, AUDIT, and substance use screening at every visit.
Affirming Care for Transgender Patients
Follow WPATH Standards of Care (Version 8, 2022) for gender-affirming medical and surgical interventions. Hormone therapy monitoring: Complete blood count, liver function, lipids, hemoglobin A1c, and hormone levels at regular intervals. Ensure continuity of gender-affirming hormones during hospitalizations and incarceration. Surgical options include chest surgery, genital surgery, and facial feminization/masculinization; informed consent models are increasingly adopted.
<image>Clinical workflow diagram for inclusive preventive care showing the patient journey from registration (inclusive forms, SOGI data collection) through clinical encounter (affirming communication, comprehensive history including sexual practices, organ inventory for appropriate screening), tailored preventive services (STI screening, PrEP assessment, cancer screening based on anatomy, mental health evaluation), and follow-up (community resources, referrals to affirming specialists)</image>
Key Clinical Pearls
Sexual orientation and gender identity are distinct constructs; sexual behavior may not align with stated identity, making behavioral history essential for appropriate preventive care. PrEP is one of the most effective biomedical HIV prevention tools available; preventive medicine physicians should screen for PrEP eligibility and reduce barriers to access. Cancer screening for transgender patients must be guided by current anatomy, not gender identity; develop an organ inventory for each patient. Family acceptance is the single most protective factor for LGBTQ+ youth mental health; family-based interventions should be prioritized.
References
- Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003;129(5):674-697.
- Streed CG, Beach LB, Caceres BA, et al. Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association. Circulation. 2021;144(6):e136-e148.
- Ryan C, Huebner D, Diaz RM, Sanchez J. Family rejection as a predictor of negative health outcomes in white and Latino lesbian, gay, and bisexual young adults. Pediatrics. 2009;123(1):346-352.
- Coleman E, Radix AE, Bouman WP, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022;23(Suppl 1):S1-S259.
